Affiliation:
1. Department of Neurology, Huashan Hospital, State Key Laboratory for Medical Neurobiology MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai 200032, China
2. Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Abstract
Background & Objective:
Tenidap, a selective human inwardly rectifying potassium (Kir)
2.3 channel opener, has been reported to have antiepileptic effect in the pilocarpine temporal lobe epilepsy
rat model in our previous study. However, the effect of tenidap on neurons and its relationship
with the epileptiform bursting charges in neuron is still required to be explored.
Methods:
In this study, cyclothiazide (CTZ) induced cultured hippocampal neuron epileptic model
was used to study the antiepileptic effect of tenidap and the relationship between Kir2.3 channel and
the neuronal epileptiform burst.
Results:
Patch clamp recording showed that both acute (2h) and chronic (48h) CTZ pre-treatment all
significantly induced robust epileptiform burst activities in cultured hippocampal neurons, and tenidap
acutely application inhibited this highly synchronized abnormal activities. The effect of tenidap is likely
due to increased activity of Kir2.3 channels, since tenidap significantly enhanced kir current recorded
from those neurons. In addition, neurons overexpressing Kir2.3 channels, by transfection with
Kir2.3 plasmid, showed a significant large increase of the Kir current, prevented CTZ treatment to induce
epileptiform burst discharge.
Conclusion:
Our current study demonstrated that over activation of Kir2.3 channel in hippocampal
neurons could positively interference with epileptiform burst activities, and tenidap, as a selective
Kir2.3 channel opener, could be a potential candidate for seizure therapy.
Funder
Shanghai Municipal Science and Technology Major Project
Nature Science Foundation of China
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,General Neuroscience
Reference37 articles.
1. Ali A.; Ahmad F.J.; Pillai K.K.; Vohora D.; Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior. Epilepsy Behav 2004,5,322-328
2. Deng X.; Xie Y.; Chen Y.; Effect of neuroinflammation on ABC transporters. Possible contribution to refractory epilepsy. CNS Neurol Disord Drug Targets 2018,17,728-735
3. Ying X.; Wang Y.; Liang J.; Angiopep-conjugated electro-responsive hydrogel nanoparticles: Therapeutic potential for epilepsy. Angew Chem Int Ed Engl 2014,53,12436-12440
4. Shuzhang Z.; Yudan Z.; Zhiping Z.; Jie T.; Yong-Hua J.; Understanding genotypes and phenotypes of the mutations in voltage- gated sodium channel α subunits in epilepsy. CNS Neurol Disord Drug Targets 2018,17,1-7
5. Ohno Y.; Tokudome K.; Therapeutic role of Synaptic Vesicle glycoprotein 2A (SV2A) in modulating epileptogenesis. CNS Neurol Disord Drug Targets 2017,16,463-471
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献